Thirteen Weeks Ended | ||||||||
March 28, | March 30, | |||||||
2020 | 2019 | |||||||
Net loss | $ | (9,751 | ) | $ | (35,268 | ) | ||
Income tax provision (benefit) | (9,290 | ) | 4,800 | |||||
Interest expense, net | 23,180 | 26,563 | ||||||
Interest expense on junior subordinated debentures | 3,152 | 3,152 | ||||||
Investment income on trust common securities | (95 | ) | (95 | ) | ||||
Depreciation | 17,517 | 15,816 | ||||||
Amortization | 14,848 | 14,765 | ||||||
EBITDA | 39,561 | 29,733 | ||||||
Stock compensation expense | 1,145 | 361 | ||||||
Management fees | 125 | 131 | ||||||
Acquisition and integration expense | 329 | 1,098 | ||||||
Retention and long term incentive bonuses | — | 2,030 | ||||||
Non-recurring legal fees | 781 | — | ||||||
Canada Restructuring (1) | 1,732 | (64 | ) | |||||
U.S. Restructuring (2) | 131 | — | ||||||
Restructuring and other costs (3) | 953 | 4,726 | ||||||
Change in fair value of contingent consideration | (4,400 | ) | — | |||||
Mark-to-market adjustment on interest rate swaps | 2,250 | 1,113 | ||||||
Adjusted EBITDA | $ | 42,607 | $ | 39,128 |
1. | Includes charges related to a restructuring plan announced in our Canada segment in 2018, including facility consolidation and charges relating to exiting certain lines of business. See Note 9 - Restructuring of the Notes to the Condensed Consolidated Financial statements for additional information. |
2. | Includes charges related to a restructuring plan announced in our United States business in the fourth quarter of 2019, including severance related to management realignment and the integration of sales and operating functions. See Note 9 - Restructuring of the Notes to the Condensed Consolidated Financial statements for additional information. |
3. | Includes one time charges associated with new business wins along with consulting and other costs associated with streamlining our manufacturing and distribution operations. |